Cellusion CEO Shin Hatou will speak at International Session 3 of the 78th Annual Congress of Japan Clinical Ophthalmology.

■The 78th Annual Congress of Japan Clinical Ophthalmology Date: November 14(Thu.) – 17 (Sun.), 2024
Venue: Kyoto International Conference Center (ICC Kyoto), The Prince Kyoto Takaragaike
Theme: Contribution to the future

■Hatou’s lecture
Thursday, November 14, 15:40-17:00, Room 5
International Session 3
Cornea Clinics Part 2: Surgical therapy -present and future-
Theme: Development of cell therapy for bullous keratopathy using iPS cells

Cellusion will participate in BIO Asia-Taiwan 2024, a gathering of bioindustry executives and investors from Asia and around the world, and CFO Takuya Kaneko is scheduled to make a pitch at the Investment Summit.
BIO Asia-Taiwan 2024
Investment Summit Session 4 / Pitch
Thursday, July 25, 2024, 10:50 a.m. – 12:30 p.m. (TST)
Venue: Nangang Exhibition Center, TaiNEX2 7F

Cellusion will exhibit at HVC KYOTO (Healthcare Venture Conference KYOTO) 2024 Demo Day (Day2), an innovation platform organized by Kyoto Research Park Corp. (KRP) and Japan External Trade Organization (JETRO), co-hosted with Kyoto Prefecture and Kyoto City.
DemoDay Day2: Tuesday, July 9, 2024, 10:00 a.m. – 5:00 p.m.（JST）
Venue: Kyoto Research Park (93 Chudoji Awata-cho, Shimogyo-ku, Kyoto)

Cellusion CEO Shin Hatou will give a special lecture at the 6th Regenerative Medicine Expo TOKYO (June 26-28, 2024 at Tokyo Big Sight, Japan), where approximately 900 companies will exhibit regenerative medicine-related products and services.

Thursday, June 27, 4:00 p.m.-
Regenerative Medicine EXPO Special Session 4 / RM-S4
Lecture title: “Realization of New Corneal Regenerative Medicine Using iPS Cells”

Cellusion exhibits at the Japan Pavilion organized by JETRO
at the 2024 BIO International Convention

Cellusion CEO Shin Hatou will deliver a special lecture and participate in a panel discussion at ”The 5th International Cell & Gene Therapy China Summit & Exhibition” (CGCS2024 May 22-24, 2024), one of the largest cell and gene therapy events in APAC, to be held in Nanjing, China.

Cellusion CEO Shin Hatou will speak on “Research and development of new corneal regenerative medicine using iPS cells” at the Minaris Regenerative Medicine’s luncheon seminar at the 23rd Congress of the Japanese Society for Regenerative Medicine on March 23, 2024.

Cellusion will exhibit at “Genesis 2023” in London

Cellusion CFO Takuya Kaneko will join the “GROWTH INDUSTRY CONFERENCE 2023” pitch contest on November 16.

Cellsion wins a prize in the Japan Semi-Final
of the JINJI LAKE STARTUP CONTEST 2023